This is the first gene therapy for AADC deficiency to receive US regulatory approval and the first that can be administered directly to the brain.
The FDA updated GLP-1 drug labels to warn of the risk of patients breathing food into their lungs while under anesthesia for ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback